[HTML][HTML] The role of direct oral anticoagulants in the era of COVID-19: are antiviral therapy and pharmacogenetics limiting factors?
In patients with COVID-19, thromboinflammation is one of the main causes of morbidity and
mortality, which makes anticoagulation an integral part of treatment. However …
mortality, which makes anticoagulation an integral part of treatment. However …
The role of direct oral anticoagulants in the era of COVID-19: are antiviral therapy and pharmacogenetics limiting factors?
H Roguljić, J Arambašić, V Ninčević… - Croatian medical …, 2022 - pubmed.ncbi.nlm.nih.gov
In patients with COVID-19, thromboinflammation is one of the main causes of morbidity and
mortality, which makes anticoagulation an integral part of treatment. However …
mortality, which makes anticoagulation an integral part of treatment. However …
[PDF][PDF] The role of direct oral anticoagulants in the era of COVID-19: are antiviral therapy and pharmacogenetics limiting factors?
M Smolić - Croat Med J, 2022 - scienceopen.com
In December 2019, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
infection causing COVID-19 reached the epidemic proportions. Since then, the disease has …
infection causing COVID-19 reached the epidemic proportions. Since then, the disease has …
[PDF][PDF] The role of direct oral anticoagulants in the era of COVID-19: are antiviral therapy and pharmacogenetics limiting factors?
M Smolić - Croat Med J, 2022 - researchgate.net
In December 2019, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
infection causing COVID-19 reached the epidemic proportions. Since then, the disease has …
infection causing COVID-19 reached the epidemic proportions. Since then, the disease has …
[PDF][PDF] The role of direct oral anticoagulants in the era of COVID-19: are antiviral therapy and pharmacogenetics limiting factors?
M Smolić - Croat Med J, 2022 - draganprimorac.com
In December 2019, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
infection causing COVID-19 reached the epidemic proportions. Since then, the disease has …
infection causing COVID-19 reached the epidemic proportions. Since then, the disease has …
The role of direct oral anticoagulants in the era of COVID-19: are antiviral therapy and pharmacogenetics limiting factors?
H Roguljić, J Arambašić, V Ninčević… - Croatian Medical …, 2022 - search.ebscohost.com
In patients with COVID-19, thromboinflammation is one of the main causes of morbidity and
mortality, which makes anticoagulation an integral part of treatment. However …
mortality, which makes anticoagulation an integral part of treatment. However …
The role of direct oral anticoagulants in the era of COVID-19: are antiviral therapy and pharmacogenetics limiting factors?
H Roguljić, J Arambašić, V Ninčević… - Croatian medical …, 2022 - unirepository.svkri.uniri.hr
In December 2019, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
infection causing COVID-19 reached the epidemic proportions. Since then, the disease has …
infection causing COVID-19 reached the epidemic proportions. Since then, the disease has …
The role of direct oral anticoagulants in the era of COVID-19: are antiviral therapy and pharmacogenetics limiting factors?
H Roguljić, J Arambašić, V Ninčević, L Kuna… - Croatian medical …, 2022 - croris.hr
Sažetak In patients with COVID-19, thromboinflammation is one of the main causes of
morbidity and mortality, which makes anticoagulation an integral part of treatment. However …
morbidity and mortality, which makes anticoagulation an integral part of treatment. However …
The role of direct oral anticoagulants in the era of COVID-19: are antiviral therapy and pharmacogenetics limiting factors?
H Roguljić, J Arambašić, V Ninčević… - Croatian medical …, 2022 - repository.medri.uniri.hr
Abstract (english) In patients with COVID-19, thromboinflammation is one of the main causes
of morbidity and mortality, which makes anticoagulation an integral part of treatment …
of morbidity and mortality, which makes anticoagulation an integral part of treatment …
The role of direct oral anticoagulants in the era of COVID-19: are antiviral therapy and pharmacogenetics limiting factors?
H Roguljić, J Arambašić, V Ninčević, L Kuna… - Croatian Medical …, 2022 - europepmc.org
In patients with COVID-19, thromboinflammation is one of the main causes of morbidity and
mortality, which makes anticoagulation an integral part of treatment. However …
mortality, which makes anticoagulation an integral part of treatment. However …